DOCSLIB.ORG

Latest List of General Sales Product Information

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Latest List of General Sales Product Information Latest General Sales Product Information This list was last updated on Friday, October 1, 2021 Please Note The contents of the table are believed to be correct at the time of compilation. The HPRA makes no representations or warranties about and disclaim all liability for the content, accuracy, completeness or suitability of the information contained in the table for any purpose whatsoever and the information is made available to the public for information purposes only. For any conditions associated with this general sale classification please refer to the detailed product information on the Human Medicines Product listing on the HPRA website. Please note that at time of print some products listed below may not be currently marketed. Part 1. Supply through non-pharmacy outlets and pharmacies Trade Name Licence Holder Licence Strength Dosage Form Active Number Ingredients Acic Cold Sore 5% Rowex Ltd PA0711/017/006 5 percent Cream -ACICLOVIR w/w Cream weight/weight Aconite A. Nelson & HOR1149/001/001 6C-MM -Aconitum napellus Company Limited After Bite 3.5% w/v Zenview Limited PA22919/001/001 3.5 percent Cutaneous -Ammonia Cutaneous weight/volume emulsion Emulsion Agnus castus oral A. Vogel Ireland TR2309/017/001 . Oral drops -Tincture from drops Limited agnus castus fruits Alka-Seltzer Bayer Limited PA1410/032/001 324 mg/1744 Effervescent tablet -Sodium hydrogen Effervescent mg/965 milligram(s carbonate Tablets -Aspirin Acetylsalicylic Acid -Citric acid (Aspirin) 324mg anhydrous Sodium Hydrogen Carbonate 1744mg Citric Acid 965mg Amylmetacresol/2, McDermott PA0577/192/001 0.60/1.2 Lozenge -2,4 4-Dichlorobenzyl Laboratories Ltd., milligram(s) DICHLOROBENZ alcohol Mylan 0.6 T/A Gerard YL ALCOHOL mg/1.2 mg honey & Laboratories -Amylmetacresol lemon lozenges Amylmetacresol/2, McDermott PA0577/192/002 0.60/1.2 Lozenge -2,4 4-Dichlorobenzyl Laboratories Ltd., milligram(s) DICHLOROBENZ alcohol Mylan 0.6 T/A Gerard YL ALCOHOL mg/1.2 mg mint Laboratories -Amylmetacresol lozenges Anadin Analgesic GlaxoSmithKline PA0678/148/001 325/15 milligram(s) Film-coated tablet -Aspirin Film-coated Tablets Consumer -Caffeine Aspirin 325mg Healthcare (Ireland) Caffeine 15mg Limited Anadin Maximum GlaxoSmithKline PA0678/148/002 500 mg/32 Capsule, hard -Caffeine Strength Hard Consumer milligram(s) -Aspirin Capsules Aspirin Healthcare (Ireland) 500mg, caffeine Limited 32mg Andrews Liver Salts GlaxoSmithKline PA0678/043/001 <br/> Effervescent -Magnesium Effervescent Consumer powder sulphate dihydrate Powder Healthcare (Ireland) -Citric acid Limited anhydrous -Sodium hydrogen carbonate Latest General Sales Product Information Page 1 of 21 Trade Name Licence Holder Licence Strength Dosage Form Active Number Ingredients Antiseptic Throat The Boots PA0004/055/001 0.6 milligram(s) Lozenge -Amylmetacresol Lozenges Orange Company Plc & Menthol Anusol Cream SOFIBEL PA22647/001/001 2.14/1.8/1 gram(s) Cream -Bismuth oxide -Balsam peru -Zinc oxide Anusol Ointment SOFIBEL PA22647/001/002 0.875g/100g + Ointment -Bismuth subgallate 1.875g/100g + -Bismuth oxide 10.75g/100g + 2.25 -Balsam peru gram/100gram -Zinc oxide Aqueous Cream Ovelle Limited PA0206/021/001 9% w/w + 15% w/w Cream -Emulsifying wax Emulsifying Wax + 6 percent -White soft paraffin 9% w/w, White Soft weight/weight -Liquid paraffin Parafin 15% w/w, Liquid Paraffin 6% w/w Arnica A. Nelson & HOR1149/031/001 6X-MM Tablet -Arnica montana Company Limited (ghp) Arnica Nelsons GmbH HOR22892/002/00 6X-MM percent Pillules -Arnica montana 1 volume/volume ARNICA - Weleda (UK) HOR0407/014/001 6C & 30C Tablets -ARNICA TABLETS Limited MONTANA Artichoke-Milk A. Vogel Ireland TR2309/015/001 . Tablet -Dry extract from Thistle Complex Limited fresh cynara Tablets scolymus l. leaves (1:30-31) extraction solvent:ethanol 65% v/v -Dry extract from silybum marianum l. gaertn fruits (1:2.0-2.1) extration solvent ethanol 58% v/v -Dry extract from fresh dandelion root&herb(taraxacu m officinalis web) (1:17-18) extraction solvent:ethanol 51% -Dry extract from peumus boldus molina (1:10-11) extraction solvent:ethanol 70% v/v Aspirin 300mg Bayer Limited PA1410/037/001 300 milligram(s) Effervescent tablet -Aspirin Effervescent tablet Atrogel Arnica Gel A. Vogel Ireland TR2309/001/001 . Gel -Arnica montana l. Limited flowers (der 1:20) Atrosan Devil's A. Vogel Ireland TR2309/003/001 . Film-coated tablet -Devil's claw extract Claw film-coated Ltd, (as dry root) tablets AvenaCalm Avena A. Vogel Ireland TR2309/012/001 . Oral drops -Tincture from sativa oral drops Ltd, pressed juice from avena sativa l, herba rec (fresh oat herb),(1:1.2) Belladonna A. Nelson & HOR1149/006/001 6C-MM -Atropa belladonna Company Limited Latest General Sales Product Information Page 2 of 21 Trade Name Licence Holder Licence Strength Dosage Form Active Number Ingredients BENYLIN Non- Johnson & Johnson PA0330/021/001 100 mg/5 ml + 1.1 Syrup -Guaifenesin drowsy for Chesty (Ireland) Limited mg/5ml -Levomenthol Coughs SyrupGuaifenesin 100mg/ 5mlLevomenthol 1.1mg/ 5ml Benylin Phlegm McNeil Healthcare PA0823/066/001 100 mg/5ml Oral solution -Guaifenesin Cough Menthol 100 (Ireland) Ltd mg/5 ml oral solution Benylin Phlegm Johnson & Johnson PA0330/052/001 100 mg/5ml + 1.1 Syrup -Levomenthol Cough (Ireland) Limited mg/5ml -Guaifenesin SyrupGuaifenesin 100 mg/5ml Levomenthol 1.1 mg/ 5 ml Syrup Bepantiseptic First Bayer Limited PA1410/047/001 1.2 %w/w/0.25 Cream -Phenol Aid Cream percent -Chlorhexidine weight/weight digluconate Bisodol Antacid Teva B.V. PA1986/071/001 522/68/64 Chewable tablet -Calcium carbonate Chewable milligram(s) -Light magnesium TabletsCalcium carbonate Carbonate -Sodium hydrogen 522mgMagnesium carbonate Carbonate Light 68mgSodium Hydrogen Carbonate 64mg Bonjela Reckitt Benckiser PA0979/001/001 8.714%w/w Oromucosal gel -Choline salicylate Oromucosal Ireland Ltd +0.010<br/> -Cetalkonium GelCholine percent chloride Salicylate weight/weight 8.714%Cetalkoniu m Chloride 0.010% Bonjela Teething Reckitt Benckiser PA0979/001/003 8.714 %w/w+ 0.010 Oromucosal gel -Choline salicylate Gel Oromucosal Ireland Ltd percent -Cetalkonium GelCholine weight/weight chloride Salicylate 8.714%Cetalkoniu m Chloride 0.010% Boots Taw Pharma PA23081/003/001 2 percent Cream -Mepyramine Pharmaceuticals (Ireland) Ltd weight/weight maleate Bite and Sting Relief Antihistamine 2% w/w Cream Boots The Boots PA0004/057/001 0.6 milligram(s) Lozenge -Amylmetacresol Pharmaceuticals Company Plc Sore Throat Relief Lemon Flavour 0.6 mg Lozenges Latest General Sales Product Information Page 3 of 21 Trade Name Licence Holder Licence Strength Dosage Form Active Number Ingredients Bronchoforce A. Vogel Ireland TR2309/010/001 . Oral drops, solution -Tincture from fresh chesty cough oral Ltd, ivy herb (hedera drops helix l.) (1:5.7-6.0) extraction solvent: ethanol 51% v/v. -Tincture from fresh aerial parts of thyme (thymus vulgaris l.) (1:8.0- 8.2) extraction solvent: ethanol 51% v/v -Tincture from liquorice root (glycyrrhiza glabra l.) (1:10-11) extraction solvent: ethanol 51% v/v. Bronchosan dry, A. Vogel Ireland TR2309/008/001 .<br/> Syrup tickly cough syrup Limited Bryonia A. Nelson & HOR1149/007/001 6C-MM -Bryonia cretica Company Limited Buttercup Kwizda Pharma TR2006/001/002 .<br/> Pastille -Thyme herb dry Bronchostop Berry GmbH extract 7-13:1, Flavour Cough native extraction Pastilles solvent: water Buttercup Kwizda Pharma TR2006/001/001 .<br/> Syrup -Thyme herb Bronchostop Cough GmbH extract der 7-13:1, Syrup extraction medium: water, native -Marshmallow liquid extract der 1:12-14, extraction medium: water, native Calamine Lotion, Ovelle Limited PA0206/016/002 15 %w/v + 5 Cutaneous -Zinc oxide cutaneous percent suspension -Calamine suspension weight/volume Caldease 15% w/w Clonmel Healthcare PA0126/153/001 15 percent Ointment -Zinc oxide Medicated Ltd weight/weight Ointment Caldesene 10% Clonmel Healthcare PA0126/152/001 10 percent Cutaneous powder -Calcium w/w Medicated Ltd weight/weight undecylenate Powder Caldesene Adult Clonmel Healthcare PA0126/247/001 10 percent -Calcium 10% w/w Ltd weight/weight undecylenate Medicated Powder Calpol 120 mg/ 5 Johnson & Johnson PA0330/017/004 120 mg/5ml Oral suspension -Paracetamol ml Sugar Free (Ireland) Limited Infant Oral Suspension Calpol 120 mg/5 ml Johnson & Johnson PA0330/017/001 120 mg/5ml Oral suspension -PARACETAMOL Infant Oral (Ireland) Limited Suspension Calpol Six Plus Johnson & Johnson PA0330/017/002 250 mg/5ml Oral suspension -Paracetamol 250mg/5ml Oral (Ireland) Limited Suspension Calpol Six Plus Johnson & Johnson PA0330/017/003 250 mg/5ml Oral suspension -Paracetamol 250mg/5ml (Ireland) Limited Sugar/Colour Free Oral Suspension Latest General Sales Product Information Page 4 of 21 Trade Name Licence Holder Licence Strength Dosage Form Active Number Ingredients Calpol Six Plus Johnson & Johnson PA0330/017/005 250 milligram(s) Orodispersible -Paracetamol Fastmelts 250 mg (Ireland) Limited tablet Paracetamol Orodispersible Tablets Carnation Callous Cuxson Gerrard PA23188/001/002 40 percent Medicated plaster -Salicylic acid Caps 40% w/w Healthcare Limited weight/weight Medicated plasters Carnation Corn Cuxson Gerrard PA23188/001/001 40 percent Medicated plaster -Salicylic acid Caps 40% w/w Healthcare Limited weight/weight Medicated plasters Carnation Vericap Cuxson Gerrard PA23188/001/003 10 percent Medicated plaster -Salicylic acid Verruca Treatment Healthcare Limited weight/weight 10% w/w medicated plaster Chlorhexidine Ecolab PA1843/003/001 0.2 percent Oromucosal -Chlorhexidine Gluconate Deutschland GmbH weight/volume solution
Load more

Recommended publications
  • Consumer Superbrands 2019 Top 10 Consumer Superbrands Relevancy
    Consumer Superbrands 2019 Top 10 Consumer Superbrands BRAND CATEGORY LEGO 1 Child Products - Toys and Education Apple 2 Technology - General Gillette 3 Toiletries - Men's Grooming Rolex 4 Watches British Airways 5 Travel - Airlines Coca-Cola 6 Drinks - Non-Alcoholic - Carbonated Soft Drinks Andrex 7 Household - Kitchen Rolls, Toilet Roll and Tissues Mastercard 8 Financial - General Visa 9 Financial - General Dyson 10 Household & Personal Care Appliances Relevancy Index Top 20 BRAND CATEGORY Amazon 1 Retail - Entertainment & Gifts Aldi 2 Retail - Food & Drink Macmillan Cancer Support 3 Charities Netflix 4 Media - TV Google 5 Social, Search & Comparison Sites Lidl 6 Retail - Food & Drink PayPal 7 Financial - General LEGO 8 Child Products - Toys and Education Samsung 9 Technology - General YouTube 10 Social, Search & Comparison Sites Visa 11 Financial - General Heathrow 12 Travel - Airports Purplebricks 13 Real Estate Cancer Research UK 14 Charities Oral-B 15 Toiletries - Oral Care Apple 16 Technology - General Dyson 17 Household & Personal Care Appliances TripAdvisor 18 Travel - Agents & Tour Operators Nike 19 Sportswear & Equipment Disney 20 Child Products - Toys and Education continues... Consumer Superbrands 2019 Category Winners CATEGORY BRAND Automotive - Products Michelin Automotive - Services AA Automotive - Vehicle Manufacturer Mercedes-Benz Charities Cancer Research UK Child Products - Buggies, Seats and Cots Mamas & Papas Child Products - General JOHNSON'S Child Products - Toys and Education LEGO Drinks - Alcoholic - Beer, Ale
    [Show full text]
  • Reckitt Benckiser 0000 Paracetamol Posology Update 2019-04
    Reckitt Benckiser 0000 Paracetamol Posology Update 2019-04 Package Leaflet: Information for the User • Sodium (129.0mg per sachet), main component of cooking/table salt. This is equivalent to 6.45% of RB Artwork and Lemsip Max Honey & Ginger Flavour Powder for Oral Solution the recommended maximum daily dietary intake of sodium for an adult. Print Specification (paracetamol and phenylephrine hydrochloride) 3. How to take this medicine Trident Reference No: RB251338 Please read this leaflet carefully before you take this medicine. If you are not sure of anything ask your To be made into a hot drink. Dissolve one sachet in a mug of hot but not boiling water. Stir until dissolved. If preferred sweeten to taste with sugar, honey or your usual sweetener. ZEN Ref: TR1197000 pharmacist or doctor. 250 It is important to drink plenty of fluids when suffering from colds and flu. Action: D 1. What this medicine is and what it is used for? Adults, the elderly and children 16 years and over: Brand: Lemsip Lemsip Max Honey & Ginger Flavour Powder for Oral Solution contains a combination of ingredients One sachet every 4-6 hours as required. Do not take more than 4 sachets in 24 hours. Category: Max which are effective in relieving the symptoms associated with colds and flu, including relief of aches and Segment Group: Cold & Flu pains, sore throats, headache, nasal congestion and lowering of temperature. Do not give to children under 16 years. Segment: Honey & Ginger Paracetamol is a well-known painkiller (analgesic). It is effective against aches and pains, including a headache, If the symptoms of your cold or flu persist for more than three days, or worsen, consult your pharmacist.
    [Show full text]
  • COVID-19 Public Policy Group Report April 25, 2020
    COVID-19 Public Policy Group Report April 25, 2020 President Donald Trump on Friday signed the US$484 Tax and Economic Development Updates billion Paycheck Protection Program and Health Care Enhancement Act into law, triggering a joint announcement With the interim PPP funding bill now signed into law, the by the U.S. Department of the Treasury and Small Business SBA and Treasury Department have indicated that applications Administration (SBA) that the CARES Act‘s Paycheck will be accepted again beginning at 10:30am on Monday, April Protection Program (PPP) will resume operations Monday 27. In a joint statement, Treasury Secretary Mnuchin and SBA morning at 10:30am EST. Meanwhile, details continued to Administrator Jovita Carranza noted: “The PPP has supported trickle out about the respective agendas of the White House more than 1.66 million small businesses and protected and Democratic congressional leadership for negotiations over 30 million jobs for hardworking Americans…With the over the next federal COVID-19 response measure. additional funds appropriated by Congress, tens of millions of additional workers will benefit from this critical relief.” The House Speaker Nancy Pelosi (D-CA) and her lieutenants will two also made clear that the SBA “has properly coded the have the pen in writing the first iteration of the next pandemic system to account for changes,” including the US$60 billion response bill, which House Majority Leader Steny Hoyer (D- set aside for smaller financial institutions. Additionally, the MD) has indicated will be unveiled by May 4. SBA yesterday published additional PPP guidance regarding Congressional Democrats are reportedly eyeing the inclusion requirements for promissory notes, authorizations, affiliation, of another round of direct “stimulus” cash payments to and eligibility.
    [Show full text]
  • Rb-Annual-Report-2012.Pdf
    Reckitt Benckiser Group plc Reckitt Benckiser Group Healthier Happier Annual Report and Financial Statements 2012 Stronger Reckitt Benckiser Group plc Annual Report and Financial Statements 2012 Contents 1 Chairman’s Statement 2 Chief Executive’s Statement 10 Business Review 2012 18 Board of Directors and Executive Committee 19 Report of the Directors 22 Chairman’s Statement on Corporate Governance 24 Corporate Governance Report 30 Statement of Directors’ Responsibilities 31 Directors’ Remuneration Report 38 Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 39 Group income statement 39 Group statement of comprehensive income 40 Group balance sheet 41 Group statement of changes in equity 42 Group cash flow statement 43 Notes to the financial statements 75 Five-year summary 76 Parent Company – Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 77 Parent Company balance sheet 78 Notes to the Parent Company financial statements 84 Shareholder information Chairman’s Statement largest consumer health care category in The Board conducted its regular reviews the world with the acquisition of Schiff of the Company’s brands, geographic area Nutrition International, Inc. (Schiff) and and functional performance together with its leading US brands in the vitamins, detailed reviews of its human resources. minerals and supplements market. There The Board also completed its annual were also a few disposals of non core assessment of corporate governance assets. Net debt at the end of 2012, after including Board performance, corporate paying for dividends, net acquisitions and responsibility, and reputational and organisation restructuring, stood at business risk. £2,426m (2011: £1,795m). AGM Resolutions Your Board proposes an increase in the final The resolutions, which will be voted dividend of +11%, taking it to 78p per upon at our AGM of 2 May 2013 are share, and bringing the total dividend for fully explained in the Notice of Meeting.
    [Show full text]
  • Northern Ireland Prescription Code Book Drugs Section September 2021
    Family Practitioner Services, Pharmaceutical Services, 2 Franklin Street, Belfast BT2 8DQ Telephone No. 028 9053 5613, Fax No. 028 9053 2963 Northern Ireland Prescription Code Book Drugs section September 2021 Page 1 of 587 Effective for prescriptions dispensed September 2021 BSO Code dm+d Pack Description Code Number Special ZD Of Container 38960 4SURE beta-ketone testing strips 4S-810-4183401-001 (Nipro Diagnostics (UK) Ltd) 10 strip strips 38961 4SURE testing strips (Nipro Diagnostics (UK) Ltd) 50 strip strips 4144 AAA 1.5mg/dose sore throat spray (Manx Healthcare Ltd) 60 dose [BSO pack = 1] BSO Unit Of Measure Code No. devices dispensed 70598 (DT) Abacavir 600mg / Lamivudine 300mg tablets 30 tablet tablets 9154 Abasaglar 100units/ml solution for injection 3ml cartridges (Eli Lilly and Company Ltd) 5 cartridge cartridges ZD 9038 Abasaglar KwikPen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) 5 pre- injections ZD filled disposable injection 70088 (DT) Abatacept 125mg/1ml solution for injection pre-filled disposable devices 4 pre-filled disposable injections ZD injection 70089 (DT) Abatacept 125mg/1ml solution for injection pre-filled syringes 4 pre-filled disposable injection injections ZD 70144 Abelcet 100mg/20ml concentrate for suspension for infusion vials (Teva UK Ltd) 10 vial vials Hospital Only 3303 Abidec Multivitamin drops (Omega Pharma Ltd) 25 ml mls 4043 Abilify 10mg orodispersible tablets (Otsuka Pharmaceuticals (U.K.) Ltd) 28 tablet 4 x 7 tablets tablets 3006 Abilify 10mg tablets (Otsuka
    [Show full text]
  • Betterbusiness Betterfinancials How We Drive Growth and Outperformance
    Reckitt Benckiser Group plc Annual Report and Financial2015 Statements betterbusiness 2015 Reckitt Benckiser Group plc (RB) Annual Report and Financial Statements We make a difference to people’s lives through a trusted portfolio of brands, across consumer health, hygiene and home. Our vision Our purpose A world where people are To make a difference, by healthier and live better. giving people innovative solutions for healthier lives and happier homes. Our strategy betterbusiness betterfinancials How we drive growth and outperformance Chief Executive’s Review on pages 8–9 bettersociety betterenvironment How we support How we reduce our communities and our environmental develop our people impact Strategic framework on pages 12–13 Contents Strategic Report bettersociety Governance Report 1 Highlights 24 – Workplace 46 Board of Directors 2 At a glance 26 – Communities 50 Executive Committee 4 Chairman’s Statement 26 – Products 52 Chairman’s Statement on 7 Reasons why RB delivers betterenvironment Corporate Governance 8 Chief Executive’s Review 27 – Greenhouse gas emissions 54 Corporate Governance Statement 10 Our unique culture 28 – Water 60 Nomination Committee Report 12 Strategic framework 28 – Waste 61 Audit Committee Report 14 Our market and resources 29 – Sourcing 66 Directors’ Remuneration Report betterfinancials 30 Our operating model 68 Our remuneration at a glance 16 – Our strategy to deliver 32 Our operating model in action 70 Annual Report on Remuneration 17 – Organisation 34 Creating stakeholder value 79 Directors’ Remuneration Policy 19 – Powermarkets 36 Financial Review 85 Report of the Directors 20 – Powerbrands 40 Strategic Risks 88 Directors’ Statement of Responsibilities 22 – Virtuous earnings model Financial Statements 89 Financial Statements Any information contained in the 2015 Annual Report and Financial Statements on the price at which shares or other securities in Reckitt Benckiser Group plc have been bought or sold in the past, or on the yield on such shares or other securities, should not be relied upon as a guide to future performance.
    [Show full text]
  • Sustainable Chemicals Management: Tools and Trends
    Sustainable Chemicals Management: Tools and Trends November 18, 2015 Today’s topics and speakers Cheryl Baldwin VP of Consulting Pure Strategies Jennifer Duran Global Head of Sustainable Better Ingredients Case Study Innovation RB Bob Kerr Chemicals Management Software Co-Founder & Principal Review Pure Strategies Tim Greiner The Chemical Footprint Project & Co-Founder & Managing Director Market Trends Pure Strategies 2 Key session logistics • All attendees in listen-only mode • Use chat window for questions – during and after presentations • Some attendee-response questions – respond in chat window • Webinar is being recorded • Recorded webinar and slides-only version at www.purestrategies.com shortly after webinar 3 Pure Strategies overview • Founded 1998 – 17 years providing sustainability expertise to leading companies. • Deep experience working with: ◦ Sustainability leaders and those at earlier stages of sustainability pathway ◦ Iconic brands and less widely known companies ◦ Mix of B2C and B2B companies ◦ Food & beverage ◦ Consumer products ◦ Retail ◦ Life sciences www.purestrategies.com 4 Pure Strategies areas of expertise 5 Partial client list Today’s topics and speakers Cheryl Baldwin VP of Consulting Pure Strategies Jennifer Duran Global Head of Sustainable Better Ingredients Case Study Innovation RB Bob Kerr Chemicals Management Software Co-Founder & Principal Review Pure Strategies Tim Greiner The Chemical Footprint Project & Co-Founder & Managing Director Market Trends Pure Strategies 7 Sustainable Chemicals Management • Addressing chemicals of concern • Improving health and • Evaluating and verifying environmental profile composition • Enhancing transparency and collaboration 8 Sustainable Chemicals Management Why are companies enhancing the safety and transparency of chemicals and materials in their products and supply chains? A. Meet regulatory requirements B.
    [Show full text]
  • Rejuvenating RB Plc Group Benckiser Reckitt Annual Report and Financial Statements 2019 Statements Financial and Report Annual
    Rejuvenating RB Reckitt Benckiser Group plc Annual Report and FinancialStatements 2019 Reckitt Benckiser Group plc Annual Report and Financial Statements 20192018 INTRODUCTION CONTENTS Strategic Report Welcome 01 Financial highlights 02 Health and Hygiene Home – at a glance 04 Chairman’s statement 06 Chief Executive’s statement 10 Our business model Our purpose 12 How purpose drives our performance We exist to protect, heal and nurture in the relentless pursuit of a cleaner 14 Mapping what matters to our stakeholders and healthier world. 18 KPIs 20 Consumers Our fight 24 Customers We have a fight on our hands. A fight to make access to the highest quality 28 People hygiene, wellness and nourishment a right and not a privilege. 32 Partners 36 Communities 40 Environment 46 s172 statement 48 Health operating review 52 Hygiene Home operating review 56 Non-financial information statement 58 Financial review 64 Risk management Health 77 Viability statement Governance 78 Board of Directors 84 Executive Committee 86 Corporate Governance – Chairman’s statement 88 Corporate Governance statement 97 Nomination Committee Report 103 Audit Committee Report 111 CRSEC Committee Report 117 Directors’ Remuneration Report 138 Report of the Directors Page 48 141 Statement of Directors’ Responsibilities Financial Statements 143 Independent Auditors Report Chief Executive’s Statement 152 Financial Statements 223 Shareholder Information Hygiene Home Page 06 Page 52 STRATEGIC REPORT GOVERNANCE FINANCIAL STATEMENTS FINANCIAL HIGHLIGHTS Net Revenue Health Hygiene
    [Show full text]
  • Solid Dosage Drug Development and Manufacturing
    SUPPLEMENT TO THE APRIL 2020 ISSUE OF 2020 PharmTech.com Solid Dosage Drug Development and Manufacturing Development OTC Formulations Quality Excipient Regulations Manufacturing Tableting Factors Multi-Tip Tooling Operations OSD Production Challenges CONTRACT MANUFACTURING Biologics | ADCs | Potent | Drug Product | Fermentation Fill/Finish | Hot Melt Extrusion | APIs abbviecontractmfg.com Experience Drug Product Unrivaled When it comes to delivering drug product, you need a CMO with longstanding commercial expertise to ensure fast time to market and assurance of supply. Solid Dosage Drug Development and Manufacturing 2020 EDITORIAL DEVELOPMENT Editorial Director Rita Peters [email protected] Senior Editor Agnes Shanley [email protected] Managing Editor Susan Haigney [email protected] s4 Oral Dosage Form Innovation European Editor Felicity Thomas [email protected] in OTC Pharmaceuticals Manufacturing Editor Jennifer Markarian [email protected] Science Editor Feliza Mirasol [email protected] Gerry McNally Assistant Editor Lauren Lavelle [email protected] Senior Art Director Marie Maresco; Graphic Designer Maria Reyes Contributing Editors Jill Wechsler [email protected]; Hallie Forcinio [email protected]; QUALITY/REGULATIONS Susan J. Schniepp [email protected]; Eric Langer [email protected]; and Cynthia A. Challener, PhD [email protected] s10 Considering Excipient Regulations Correspondent Sean Milmo (Europe, [email protected]) 485 Route One
    [Show full text]
  • Statistical Analysis Plan
    Non-Interventional Study Protocol Study Code << DXXXRXXX >> Version V1.4 Date 14 July 2017 Decline In lung-function Among Patients with chronic obstructive Lung disease On maintenance therapy (DIAPLO) An observational study evaluating the benefits of early intervention with maintenance therapies to prevent or slow down rapid lung function decline in patients who are at high risk at the time of COPD diagnosis in the combined Optimum Patient Care Research Database and Clinical Practice Research Datalink databases TITLE PAGE Non-Interventional Study Protocol Study Code << DXXXRXXX >> Version 14 July 2017 Date 14 July 2017 TABLE OF CONTENTS PAGE TITLE PAGE ........................................................................................................... 1 TABLE OF CONTENTS ......................................................................................... 2 LIST OF ABBREVIATIONS .................................................................................. 5 RESPONSIBLE PARTIES ...................................................................................... 6 PROTOCOL SYNOPSIS DIAPLO STUDY ........................................................... 7 AMENDMENT HISTORY ................................................................................... 12 MILESTONES ....................................................................................................... 13 1. BACKGROUND AND RATIONALE .................................................................. 14 1.1 Background ...........................................................................................................
    [Show full text]
  • Industry Profiles
    MARKETLINE INDUSTRY PROFILES WHAT ARE MARKETLINE INDUSTRY PROFILES? MarketLine’s Industry Profiles are the ultimate go-to guide when you need reliable insights on a specific industry. Our Industry Profiles will help you to Each Industry Profile includes: Example titles: form a clear picture of individual sectors, • Forecasts for the market including who is operating within them Mining in Germany • Market value and volume data and how they are performing. • Industry segmentation Hot Drinks in China Concise and accurate, Industry Profiles • Macroeconomic analysis are presented within the globally • Competitor analysis recognized Porter’s Five Forces analysis • Leading company information framework to help you understand and We do the work for you... apply key insights in minutes. They are the ideal starting point for gaining a Profiling 2,500 individual industries, top-level understanding of individual MarketLine is one of the most prolific sectors across the globe. publishers of business information in the market. Industry Profiles are written exclusively by our expert analysts, drawing from their personal and professional expertise and primary and secondary research. HOW DID MARKETLINE GET THIS DATA? MarketLine Industry Profiles are written by our in-house analysts and prepared under an established methodology, 1. tried and tested over 10 years. PREPARATORY RESEARCH With stringent checks and controls to capture and validate the accuracy of our data, you can be confident in MarketLine to deliver quality data and insights. 2. 3. 4. 5. INDUSTRY EXTENSIVE REVIEW OF MODELING & QUALITY PROFILES SECONDARY IN-HOUSE FORECASTING CONTROL RESEARCH DATABASES WHY CHOOSE MARKETLINE? In an information-rich world, finding facts you can rely upon isn’t always easy.
    [Show full text]
  • Icontact Newsletter
    eckitt Benckiser (formerly Reckitt & C sioners of the R olman) Pensio i for pen n Fund No. 69, September 2017 IN THIS ISSUE ROUTINE INCREASE LETTER When Hull’s Weeping Window poppy display moved on, Derby put its best foot forward with a pavement trail leading to a IS ALSO A REASSURANCE display reaching new heights The April letter, tailored to the individual and sent to RBPA at the Old Silk Mill (see P3&9). members advising them of the annual increase in their pension, may be routine but, like the annual update newsletter, is a welcome reassurance in these uncertain economic times. Also on P3 see how Dansom The letter notes: ‘The level of maintain the century-old tradition Lane’s British Legion standard annual increase applied to your Fund of employee welfare, to use the old- came out of retirement for the pension is equal to the year-on-year fashioned but very relevant words. “Poppy for Oppy” display change in the Retail Prices Index In both business and Government, (RPI) at the 31 December prior to the pensions have become a numbers increase. The rate at 31 December game. Deficits thwart takeover 2016 was 2.5%. Therefore, with effect bids; underfunding or retirement from 1 April 2017, your Fund pension age extensions could impoverish will be increased by 2.5%. some pensioners; and it is reported ‘This is in accordance with the that the government relaxation to Fund’s Rules, which provide that the allow pensioners to cash-in early is Trustees must increase pensions in resulting in serious personal debt line with RPI, up to a maximum of 5%.’ problems.
    [Show full text]